Since the levels of free IL-18 are unusually high and correlate with disease severity in humans with HLH (Dinarello and Kaplanski, 2005; Mazodier et al., 2005) the present study was conducted to evaluate the therapeutic potential of neutralizing IL-18 with IL-18BP in a mouse model of HLH. Here, IL18 is linked to hemophagocytic syndrome.